IP Library Granted Patent US 9,962,294
Granted Patent B2
US 9,962,294 · App. 15/170,585 · Granted May 8, 2018

Patterned neo-epithelialization dressings, systems, and methods

Inventors: Michael Manwaring (San Antonio, TX); Braden K. Leung (San Antonio, TX)
Assignee: KCI Licensing, Inc.
A61F13/00021A61F13/00063A61M1/0088A61F13/00068A61F2013/00089A61M2210/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,962,294
App. No.
15/170,585
Granted
May 8, 2018
Kind
B2
Abstract

Systems, methods, and apparatuses are presented that involve forming patterns on neo-epithelium that allow increased functionality and may more nearly resemble the original epithelium. In one instance, a patterned neo-epithelium dressing for treating a tissue site having granulation tissue includes an interface member for placing proximate the granulation tissue and a plurality of three-dimensional features formed on a second, patient-facing side of the interface member. Other systems, methods, and apparatuses are disclosed.

Claims (34)

1. A patterned neo-epithelium dressing for treating a skin tissue site having granulation tissue, the patterned neo-epithelium dressing comprising:

an interface member having a first side; and

a second, patient-facing side configured to be placed proximate to the granulation tissue,

the second, patient-facing side of the interface member having a surface topography defined by a plurality of ridges and grooves formed in a pattern to mimic intact human skin.

2. The patterned neo-epithelium dressing of claim 1 , wherein the interface member is formed with a fluid passageway that fluidly couples the first side and the second, patient-facing side.

3. The patterned neo-epithelium dressing of claim 1 , wherein the interface member has a plurality of pores having an average pore size greater than 5 μm and smaller than 1000 μm.

4. The patterned neo-epithelium dressing of claim 1 , wherein the pattern is configured to mimic an intact analogous human skin pattern based on the patient's skin near the wound or a duplicate body part.

5. The patterned neo-epithelium dressing of claim 1 , wherein the pattern is configured to mimic a location-specific human skin pattern based on the general features of a specific area of a generic body.

6. The patterned neo-epithelium dressing of claim 1 , wherein the interface member comprises a thin member bonded to a foam.

7. The patterned neo-epithelium dressing of claim 1 , wherein the interface member comprises:

a thin member having a first side and a second, patient-facing side;

a hydrophilic material having a first side and a second, patient-facing side; and

wherein the second, patient-facing side of the hydrophilic material is coupled to the first side of the thin member.

8. The patterned neo-epithelium dressing of claim 1 , further comprising a protein coated on the plurality of ridges and grooves.

9. A method of treating a wound at a tissue site of a patient, the method comprising:

locating granulation tissue at the tissue site;

deploying a patterned neo-epithelium dressing on the granulation tissue, the dressing comprising: an interface member having (i) a first side, (ii) a second, patient-facing side, and (iii) the second patient-facing side having a surface topography defined by a plurality of ridges and grooves formed in a pattern configured to mimic intact human skin, and wherein the second, patient-facing side is deployed proximate the granulation tissue; and

applying a contact pressure on the patterned neo-epithelium dressing.

10. The method of claim 9 , wherein the locating comprises promoting the formation of granulation tissue using reduced pressure at the tissue site.

11. The method of claim 10 , wherein the step of promoting the formation of granulation tissue comprises applying a reduced-pressure manifold proximate to the tissue site, covering the reduced-pressure manifold with a sealing member, and providing reduced pressure to the reduced-pressure manifold.

12. The method of claim 9 , wherein applying the contact pressure comprises:

deploying a sealing member over the patterned neo-epithelium dressing and a portion of the patient's skin, the sealing member having a first side and a second, patient-facing side; and

providing reduced pressure to the second, patient-facing side of the sealing member.

13. The method of claim 9 , wherein applying the contact pressure comprises deploying a pressure wrap over the first side of the patterned neo-epithelium dressing.

14. The method of claim 9 , wherein the interface member has a plurality of pores having an average pore size greater than 5 μm and smaller than 1000 μm.

15. A system for treating a skin tissue site having granulation tissue on a patient, the system comprising:

a patterned neo-epithelium dressing configured to be disposed proximate to granulation tissue on the skin tissue site, wherein the patterned neo-epithelium dressing comprises: an interface member having (i) a first side, (ii) a second, patient-facing side configured to be placed proximate the granulation tissue, the second, patient-facing side having a surface topography defined by a plurality of ridges and grooves formed in a pattern configured to mimic intact human skin, and (ii) one or more fluid passageways that fluidly couple the first side and the second, patient-facing side;

a sealing member for placing over the patterned neo-epithelium dressing and the patient's epidermis;

a reduced-pressure interface fluidly coupled to the sealing member; and

a reduced-pressure source fluidly coupled to the reduced-pressure interface.

16. The system of claim 15 , the interface member has a plurality of pores having an average pore size larger than 5 μm and smaller than 1000 μm.

17. The system of claim 15 , wherein the pattern is configured to mimic intact analogous human skin pattern based on the patient's skin near the wound or a duplicate body part.

18. The system of claim 15 , wherein the pattern is configured to mimic a location-specific human skin pattern based on a specific area of a generic human body.

19. The system of claim 15 , wherein the interface member comprises a polyurethane film bonded to a foam.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
Continuity (4)
Continuation 13045302 · Mar 10, 2011
Provisional Application 61314274 · Mar 16, 2010
Provisional Application 61314236 · Mar 16, 2010
Related Publication 20160270960A1 · Sep 22, 2016